Mark E. Nunnally to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Mark E. Nunnally has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.097
-
Addition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient-important outcomes. J Eval Clin Pract. 2018 02; 24(1):222-231.
Score: 0.097
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.